Patents by Inventor HUGH GREG THOMAS
HUGH GREG THOMAS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240082230Abstract: Liquid compositions comprising nimodipine having improved nimodipine concentrations are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the liquid compositions of the present invention are also detailed herein.Type: ApplicationFiled: October 11, 2023Publication date: March 14, 2024Inventor: Hugh Greg THOMAS
-
Publication number: 20230414592Abstract: Non-aqueous liquid compositions comprising nimodipine having improved stability over aqueous compositions comprising nimodipine are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the non-aqueous liquid compositions of the present invention are also detailed herein.Type: ApplicationFiled: September 8, 2023Publication date: December 28, 2023Inventor: Hugh Greg THOMAS
-
Patent number: 11819497Abstract: Liquid compositions comprising nimodipine having improved nimodipine concentrations are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the liquid compositions of the present invention are also detailed herein.Type: GrantFiled: October 26, 2022Date of Patent: November 21, 2023Assignee: AZURITY PHARMACEUTICALS, INC.Inventor: Hugh Greg Thomas
-
Patent number: 11806338Abstract: Non-aqueous liquid compositions comprising nimodipine having improved stability over aqueous compositions comprising nimodipine are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the non-aqueous liquid compositions of the present invention are also detailed herein.Type: GrantFiled: November 19, 2021Date of Patent: November 7, 2023Assignee: AZURITY PHARMACEUTICALS, INC.Inventor: Hugh Greg Thomas
-
Patent number: 11759457Abstract: Liquid compositions comprising nimodipine having improved nimodipine concentrations are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the liquid compositions of the present invention are also detailed herein.Type: GrantFiled: October 26, 2022Date of Patent: September 19, 2023Assignee: AZURITY PHARMACEUTICALS, INC.Inventor: Hugh Greg Thomas
-
Publication number: 20230068944Abstract: Liquid compositions comprising nimodipine having improved nimodipine concentrations are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the liquid compositions of the present invention are also detailed herein.Type: ApplicationFiled: October 26, 2022Publication date: March 2, 2023Inventor: Hugh Greg Thomas
-
Publication number: 20230053961Abstract: Liquid compositions comprising nimodipine having improved nimodipine concentrations are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the liquid compositions of the present invention are also detailed herein.Type: ApplicationFiled: October 26, 2022Publication date: February 23, 2023Inventor: Hugh Greg Thomas
-
Patent number: 11517563Abstract: Liquid compositions comprising nimodipine having improved nimodipine concentrations are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the liquid compositions of the present invention are also detailed herein.Type: GrantFiled: March 30, 2022Date of Patent: December 6, 2022Assignee: Azurity Pharmaceuticals, Inc.Inventor: Hugh Greg Thomas
-
Patent number: 11413277Abstract: Non-aqueous liquid compositions comprising nimodipine having improved stability over aqueous compositions comprising nimodipine are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the non-aqueous liquid compositions of the present invention are also detailed herein.Type: GrantFiled: December 22, 2021Date of Patent: August 16, 2022Assignee: Arbor Pharmaceuticals, LLCInventor: Hugh Greg Thomas
-
Publication number: 20220218684Abstract: Liquid compositions comprising nimodipine having improved nimodipine concentrations are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the liquid compositions of the present invention are also detailed herein.Type: ApplicationFiled: March 30, 2022Publication date: July 14, 2022Inventor: Hugh Greg Thomas
-
Publication number: 20220110925Abstract: Non-aqueous liquid compositions comprising nimodipine having improved stability over aqueous compositions comprising nimodipine are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the non-aqueous liquid compositions of the present invention are also detailed herein.Type: ApplicationFiled: December 22, 2021Publication date: April 14, 2022Inventor: Hugh Greg Thomas
-
Publication number: 20220110926Abstract: Non-aqueous liquid compositions comprising nimodipine having improved stability over aqueous compositions comprising nimodipine are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the non-aqueous liquid compositions of the present invention are also detailed herein.Type: ApplicationFiled: December 22, 2021Publication date: April 14, 2022Inventor: Hugh Greg Thomas
-
Publication number: 20220071974Abstract: Non-aqueous liquid compositions comprising nimodipine having improved stability over aqueous compositions comprising nimodipine are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the non-aqueous liquid compositions of the present invention are also detailed herein.Type: ApplicationFiled: November 19, 2021Publication date: March 10, 2022Inventor: Hugh Greg Thomas
-
Patent number: 11207306Abstract: Non-aqueous liquid compositions comprising nimodipine having improved stability over aqueous compositions comprising nimodipine are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the non-aqueous liquid compositions of the present invention are also detailed herein.Type: GrantFiled: December 20, 2019Date of Patent: December 28, 2021Assignee: Arbor Pharmaceuticals, LLCInventor: Hugh Greg Thomas
-
Publication number: 20200121662Abstract: Non-aqueous liquid compositions comprising nimodipine having improved stability over aqueous compositions comprising nimodipine are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the non-aqueous liquid compositions of the present invention are also detailed herein.Type: ApplicationFiled: December 20, 2019Publication date: April 23, 2020Inventor: Hugh Greg Thomas
-
Patent number: 10576070Abstract: Non-aqueous liquid compositions comprising nimodipine having improved stability over aqueous compositions comprising nimodipine are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the non-aqueous liquid compositions of the present invention are also detailed herein.Type: GrantFiled: May 9, 2019Date of Patent: March 3, 2020Assignee: Arbor Pharmaceuticals, LLCInventor: Hugh Greg Thomas
-
Publication number: 20190262326Abstract: Non-aqueous liquid compositions comprising nimodipine having improved stability over aqueous compositions comprising nimodipine are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the non-aqueous liquid compositions of the present invention are also detailed herein.Type: ApplicationFiled: May 9, 2019Publication date: August 29, 2019Inventor: Hugh Greg Thomas
-
Publication number: 20190224180Abstract: Non-aqueous liquid compositions comprising nimodipine having improved stability over aqueous compositions comprising nimodipine are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the non-aqueous liquid compositions of the present invention are also detailed herein.Type: ApplicationFiled: April 16, 2018Publication date: July 25, 2019Inventor: Hugh Greg Thomas
-
Patent number: 10342787Abstract: Non-aqueous liquid compositions comprising nimodipine having improved stability over aqueous compositions comprising nimodipine are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the non-aqueous liquid compositions of the present invention are also detailed herein.Type: GrantFiled: April 16, 2018Date of Patent: July 9, 2019Assignee: ARBOR PHARMACEUTICALS, LLCInventor: Hugh Greg Thomas
-
Publication number: 20160346300Abstract: The invention provides pharmaceutical preparations of celecoxib in suspension, solution, and combination thereof for oral administration. Insolubility of celecoxib in water is overcome in embodiments of the invention by employing co-solvents, and liquid dosage forms having celecoxib in solution at concentrations up to 10 mg/ml are provided. Manufacturing methods for celecoxib suspensions are included in the present disclosure.Type: ApplicationFiled: May 24, 2016Publication date: December 1, 2016Inventors: JEFFREY SCOTT KIEL, THOMAS JEFFREY BRYANT, RICHARD GERARD LeVASSEUR, HUGH GREG THOMAS
